SEC Form 4 · accession 0001354488-17-000426
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Kelley
Officer — Chief Executive Officer · Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 20, 2017 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2017 | A | 213,420 | $0.00 | A | 1,379,931 | D | |
| Common StockF2 | Mar 15, 2017 | F | 96,999 | $0.68 | D | 1,282,932 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issued as payment of a portion of Mr. Kelley's bonus set forth in his employment agreement.
- F2Represents shares withheld in satisfaction of tax withholding obligations.